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Accepted 7 April 2014; Published online 14 July 2014AbstractObjectives: To evaluate a new format of a summary, which presents research from synthesized evidence to patients and the public.
Study Design and Setting: We conducted a randomized controlled trial in 143 members of the public from five countries (Canada,
Norway, Spain, Argentina, and Italy). Participants received either a new summary format (a plain language summary [PLS]) or the current
format used in Cochrane systematic reviews. The new PLS presents information about the condition and intervention, a narrative summary
of results, and a table of results with absolute numbers for effects of the intervention and quality of the evidence using Grading of Rec-
ommendations Assessment, Development, and Evaluation.
Results: With the new PLS, more participants understood the benefits and harms and quality of evidence (53% vs. 18%, P ! 0.001);
more answered each of the five questions correctly (P  0.001 for four questions); and they answered more questions correctly, median 3
(interquartile range [IQR]: 1e4) vs. 1 (IQR: 0e1), P! 0.001). Better understanding was independent of education level. More participants
found information in the new PLS reliable, easy to find, easy to understand, and presented in a way that helped make decisions. Overall,
participants preferred the new PLS.
Conclusion: This new PLS format for patients and the public is a promising tool to translate evidence from synthesized
research.  2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).
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health information to manage their health [1]. Although thereFunding: Financial support for this study was provided entirely by a
grant through the Opportunities Fund of the Cochrane Collaboration
(0F020711). The funding agreement ensured the authors’ independence in
designing the study, interpreting the data, writing, and publishing the report.
Conflict of interest: None.
* Corresponding author. Department of Clinical Epidemiology and
Biostatistics, Health Sciences Centre, McMaster University, Room 2C15,
1280 Main Street West, Hamilton, Ontario, Canada L8S 4L8. Tel.: 905-
525-9140x22296; fax: 905-522-9507.
E-mail address: santesna@mcmaster.ca (N. Santesso).
http://dx.doi.org/10.1016/j.jclinepi.2014.04.009
0895-4356/ 2015 The Authors. Published by Elsevier Inc. This is an open acc
licenses/by-nc-nd/3.0/).is a plethora of evidence about the benefits and harms of a
multitude of treatments for many conditions, this information
is typically not written in a way that optimizes understanding,
accessibility, and usability for patients and the public. Much
research has focused on the specifics of how to communicate
benefits and harms of treatments, such as whether to present
the effects in relative or absolute terms or both [2], whether
to present rates or proportions or ‘‘1-in-X formats’’ [3], and
also whether data should be presented in tables [2,4,5]. The
challenge is pulling together what we have learned from that
research into one template or format to summarize and
communicate evidence to patients and the public. In 2010,
we developed a new format for a plain language summary
(PLS) for patients, which summarized the results of aess article under the CC BY-NC-ND license (http://creativecommons.org/
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 Members of the public preferred the new plain lan-
guage summary format which presents research ev-
idence from systematic reviews in two ways:
narratively and in a table showing absolute effects
and the quality of the evidence using the approach
of Grading of Recommendations Assessment,
Development, and Evaluation.
 The new format also improved comprehension
over the format currently used in Cochrane system-
atic reviews and was perceived as just as easy to
understand as the current format which does not
include numbers or quality of evidence.
 Providing patients and the public with quantitative
results from evidence in systematic reviews, along
with an indication of the confidence in those re-
sults, may improve comprehension and help with
patient decision making.
 These findings can be used to inform organizations
who aim to provide patients and the public with in-
formation about the effects of treatments.
Cochrane systematic review about the effects of a treatment
[6]. We conducted user testing in 34 patients or members of
the public and explored issues around quantitative and qual-
itative presentations of benefits and harms, as well as con-
fidence intervals and tables. We found that participants
preferred the effects of treatments presented in words, sup-
plemented with numbers in a table, and that they largely
ignored the confidence intervals. Previous research had also
indicated that the patients want to know not only how many
people will improve or be harmed when receiving a treat-
ment but also how ‘‘sure’’ those numbers are, that is, the
quality of the evidence informing those numbers [6,7].
Therefore, we additionally experimented with how to pre-
sent effects of treatments with the quality of the evidence.
This distinction between the effect of a treatment and the
confidence in that effect has received more attention with
the use of the Grading of Recommendations Assessment,
Development, and Evaluation (GRADE) approach in sys-
tematic reviews and guidelines. The GRADE approach to
assess and present the quality of evidence for the effects
of an intervention is used by over 70 organizations and is
a standard component of Cochrane systematic reviews
[8]. GRADE distinguishes between the magnitude of the ef-
fects and the confidence or certainty in those effects (ie,
quality of evidence) when presenting information about
benefits and harms. An example to illustrate this distinction
is the figure used in GRADE where a meteorologist reports
the weather saying ‘‘I figure there’s a 40% chance of
showers, and a 10% chance we know what we’re talkingabout’’ [9]. The first part is about the size of the effect,
the 40% chance of rain, and the second part, the 10%, is
about the quality of the evidence or confidence in that ef-
fect. GRADE advocates for the use of and has developed
tables to communicate this information to decision makers.
Randomized controlled trials have shown that clinicians
and guideline panels find these tables and the information
easy to understand, accessible, and helpful when making
decisions [10,11]. However, trials testing different presenta-
tions of benefits and harms with the quality of the evidence
with patients and the public and their understanding of
these two concepts together are limited.
We conducted this randomized controlled trial to compare
a new format of a patient summary of evidence from a sys-
tematic review to the current narrative format. The new
format is based on the user testing we previously conducted
[6]. It consists of two key parts (Fig. 1). The first part is a
narrative summary of the evidence, which is divided into
three sections: an introduction to the concept of a systematic
review; background information about the condition and
treatment; and information using standardized qualitative
statements about the magnitude of the effect and the quality
of the evidence for important outcomes (eg, ‘‘Vitamin C
probably decreases how long a cold lasts by a few hours’’).
The second part of the summary is a table that presents
the same outcomes and the same qualitative statements about
the effect but also the numerical results. The absolute effects
and confidence intervals are presented in natural frequencies,
and information about the quality of the evidence for each
outcome is presented as symbols and words.
We evaluated whether the new presentation improves
understanding about the benefits and harms of an interven-
tion and the confidence in those effects, whether it im-
proves the accessibility of the information, and whether it
is preferred over other versions by patients and the public.
To ensure broad representation of members of the public,
we took a global approach by enlisting the help of the
network of Cochrane groups across disease areas and re-
gions to recruit participants.2. Methods
2.1. Study design
We conducted this randomized controlled trial via the
Internet in August 2009 in five countries (Canada, Norway,
Spain, Argentina, and Italy). Members of the Cochrane
Collaboration recruited members of the public and patients
in their country to view the results of a Cochrane systematic
review in one of two formats of a PLS: one using the new
format or one using the current format. Formats were
randomly allocated using block randomization. While
reading the summary about a health care intervention and
its effects, participants answered questions using an online
questionnaire to assess their understanding (primary
outcome), their satisfaction with the PLS, the ease of
Fig. 1. New format of plain language summary.
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review. Participants then viewed the alternate format (to
which they were not initially allocated, that is, the new
format if they were randomized to the current format and
vice versa) and were asked which of the two formats they
preferred. Participants did not receive incentives to partici-
pate in the study, and consent was provided when
answering the online questionnaire. Each entity obtained
the necessary ethical approval from their institutions or na-
tional ethics committees.
2.2. Participants
Four Cochrane groups (the Cochrane musculoskeletal
group in Canada; the Norwegian branch of the Nordic Co-
chrane Center in Norway; the Iberoamerican Cochrane
Center in Argentina and Spain; and the Italian Cochrane
Center in collaboration with the PartecipaSalute [12]) re-
cruited patients and the public who were 16 years.
Methods of recruitment included a message on Cochrane
group Web sites and an email invitation disseminated
through local consumer groups and forwarded via local pa-
tient, researcher, and health professional networks. The
message requested expression of willingness to participate
in the study and was confirmed by the local investigator.
2.3. Randomization
Eligible patients and members of the public who were
willing to participate were centrally randomized to the
new or current format of a PLS by a staff member at the
Department of Clinical Epidemiology and Biostatistics at
McMaster University who was unaware of participants’ de-
mographics or other characteristics. The randomization
sequence was generated using block randomization with
40 permuted blocks of four generated on http://www.
randomization.com. An email was sent by the local inves-
tigator to the participant with a link to the SurveyMonkey
questionnaire and PLS format to which the participant
had been allocated. Participants were not made aware of
which PLS was the current or new format.
2.4. Intervention and comparator
The new format of the PLS is based on research and
development work over the past 15 years and was finalizedTable 1. New and current format of plain language summaries of Cochrane
New format
Qualitative and quantitative description of text (absolute effects and
natural frequencies provided)
Quantitative results provided in a table
Quality of the evidence according to GRADE provided in a table
Headings for question and answer format
Flow of information follows principles of linguistic frameworks
(eg, progressive movements from introduction to ‘‘bottom line’’)
Abbreviation: GRADE, Grading of Recommendations Assessment, Develfollowing semistructured interviews and user testing with
34 members of the public [6]. Important differences be-
tween the new format and the currently used format in Co-
chrane systematic reviews are shown in Table 1. The new
format has a more structured presentation using a question
and answer approach and communicates information about
benefits and harms with reference to both the magnitude of
effect and the quality of evidence. This information is pre-
sented separately in tables as numbers and symbols and in
standardized qualitative statements [6]. Thus, readers can
use the qualitative statements, the tables, or both to under-
stand the information.
Two formats of a PLS were created for this trial. The in-
formation in the PLS was derived from a systematic review
of a common topic: Vitamin C for preventing and treating
the common cold [13]. One investigator created the new
format based on the user testing and also revised the current
PLS from the review to include similar background infor-
mation and language, but maintained the current format.
Both versions were then reviewed by the other investigators
and revised accordingly (Figs. 1 and 2). The PLS were first
written in English and then translated into Norwegian,
Spanish, and Italian by the respective investigators, as our
goal was to test the format as opposed to comprehension
of the English. We provided each PLS and the question-
naire online (in the respective language) using SurveyMon-
key (www.surveymonkey.com).2.5. Outcomes
The primary outcome was the proportion of people who
correctly understood the benefits and harms of the interven-
tion and quality of evidence. The questions were similar to
questions used in randomized controlled trials for the pub-
lic, clinicians, and health care researchers to evaluate pre-
sentation of health information [4,10]. Participants
answered five multiple-choice questions, each with five
response options (Table 3 for the specific questions marked
with the designator ‘‘a’’). The proportion of people who
correctly answered a question was averaged over the five
questions and then compared between formats.
Secondary outcomes included the proportion of people
who correctly understood each of the five questions; the
overall number of correct answers for these five questions;
comprehension of the purpose of the summary; usability;systematic reviews
Current format
Qualitative description of effects
No criteria for how to describe the quality of the evidence
Paragraph of text
No criteria for flow of information
opment, and Evaluation.
Fig. 2. Current format of plain language summary.
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format over the other. Questions about purpose and pro-
ducer of the summary were multiple-choice questions with
three options. Usability, accessibility (ie, the extent to
which the main findings are easy to find, to understand,
and to use by someone making a decision), and preference
outcome measures were also based on questions previously
used in a randomized controlled trial in clinicians and
health care researchers [10]. Usability and accessibility
were framed as positive questions and were measured on
a seven-point Likert scale: 1 (strongly disagree) to 7
(strongly agree). Preference was measured after the partic-
ipants evaluated the format to which they had been first
allocated and viewed the alternate format. Preference was
measured on a seven-point scale with a strong preference
for one format at each end. We also collected demographic
information including age, language spoken and read,
education, and frequency searching the Internet for health
information. The complete questionnaire is available in
Appendix at www.jclinepi.com.
2.6. Sample size calculation
We calculated the sample size based on the main
outcome of the study: proportion of people who understood
the benefits and harms of the intervention averaged over all
five questions. We used alpha of 0.05 and 90% power to
detect a difference of 40% in the average proportion of peo-
ple who correctly answered the questions. We used data
from two studies by Schwartz, Woloshin et al. to determine
the difference of 40%, a size of effect that we also deemed
important for this study [4,5]. In those studies, 80% of the
people who received a summary of information in a tablewith event rates answered questions correctly compared
with 20e40% of those who did not receive this informa-
tion. We estimated that, at a minimum, 32 people in each
arm needed to complete the survey in English and a total
of 32 people in each arm for all other languages combined
to allow analysis by language (English vs. other languages).
2.7. Analysis
Analysis was conducted by a statistician who was
blinded to the PLS format tested after importing data from
SurveyMonkey into SPSS Version 11. To analyze descrip-
tive variables, we calculated proportions fix. We used the
chi-square test to compare differences in proportions and
the t-test or the ManneWhitney U test for the means or me-
dians comparison using two-sided tests and considered
P ! 0.05 as statistically significant. We also conducted a
generalized linear regression model adjusting for education
level, language, and Internet experience for the primary
outcome.3. Results
In total, 193 people from five countries agreed to partic-
ipate. Given the two-step approach of initial invitation and
second contact for randomization, 154 of 193 people began
the survey and 143 (74%) completed the study: 74 exposed
to the new format first and 69 to the current format first
(Fig. 3 for study flow). The majority of participants were
female (73%) and between the ages of 26 and 65 years
(76%) with diverse levels of education, from 30% who held
a high school diploma or less to 33% who held a university
Fig. 3. Participant flow diagram. PLS, plain language summary.
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seeking health information on the Internet, from greater
than once per week to less than a couple times a year. Over-
all, demographic characteristics were similar across groups
(Table 2). Of the 143 respondents, 79 received the English
version of the PLS. Language was not a significant variable
in the linear regression, and therefore, we present results for
the two groups combined.
3.1. Understanding of benefits, harms, and quality of
evidence
More participants who received the new format of the
PLS correctly answered the comprehension questions than
those who received the current format (53% vs. 18%,
P ! 0.001). This difference was statistically significant
even after adjusting for education level, language, and
Internet experience (P ! 0.001). The linear regression,
however, showed that education level was a significant fac-
tor in overall understanding of both formats. The analyses
for each question showed that in four of the five questions,
the differences in the proportion of people who answered
the questions correctly were statistically significant
(Table 3). With the exception of the question about the
meaning of the qualitative statements and understanding
risk, the differences in the proportions with correct answerswere O40%. However, the number of participants who
correctly answered each comprehension question with the
new format did not exceed 65%. In addition, the median
number of questions answered correctly out of the five
questions was significantly greater in participants who
received the new PLS compared with the current PLS (3,
interquartile range [IQR]: 1e4) vs. 1 [IQ: 0e1],
P ! 0.001).
3.2. Comprehension of the purpose of the summary
A larger proportion of respondents who received the cur-
rent PLS understood that the summary was not about one
large study, but overall this understanding was fairly low
and not significantly different (45% vs. 32%, P 5 0.17).
On the contrary, most respondents understood that the
new PLS was produced by the Cochrane Collaboration
(89%); significantly more than with the current PLS
(67%, P ! 0.001).
3.3. Accessibility of the findings and usability
More participants exposed to the new PLS responded
that the information was reliable; easy to find; easy to un-
derstand; presented in a way to help make a decision; and
presented the most important effects. All comparisons were
Table 2. Characteristics of participants
Characteristic
New format
(n [ 74)
Current format
(n [ 69)
Women, % 74 72
Age (yr), %
!25 20 23
26e35 15 16
36e45 23 25
46e55 22 22
56e65 16 13
O66 4 1
Education, %
Some high school 15 17
High school 11 17
Some college or university 11 10
College diploma 34 19
University degree(s) 30 36
Seeks health information on Internet
Greater than once per week 24 25
Once per week 16 17
Once per month 23 20
Couple times a year 20 19
Less than a couple times a year 16 19
Health care professional, % 18 9
English speaking, % 55 55
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(Fig. 4).
3.4. Preference
Across both study arms, we found a greater preference
for the new format over the current PLS (median 3Table 3. Percentage of participants with correct answer
Concept Question
Overall understanding (mean, standard
deviation)
All five questions mentioned be
Understanding of quality of evidence In people at high risk of catchi
(such as people in extreme c
conditions), what is more ce
Understanding of quality of evidence and
risk (qualitative statements)
In an ordinary population (such
at normal risk), will vitamin C
the chance of catching a col
Ability to quantify risk (dichotomous
outcome)
How many people at normal ris
in an ordinary population) wi
cold if they take vitamin C?a
Understanding of risk When people take 8 g or high d
vitamin C as soon as a cold s
will..benefit?a
Ability to quantify risk (continuous
outcome)
In people at normal risk of catch
(or in an ordinary populati
many fewer hours will their c
they took vitamin C regularly
cold even started?a
Comprehension of purpose of summary This summary is about the resu
large study. (correct answer:
Ability to identify producer of review Who produced this summary? (
answer: Researchers of the C
Collaboration)
a The five questions included in the primary outcome of overall understan
b Analysis adjusted for education level, language, and Internet experien[‘‘somewhat prefer’’], IQR: 1e6), although participants
generally preferred the format to which they were exposed
first.4. Discussion
The development and testing of the PLS over the past
15 years has provided important information and feedback
about a potentially useful format to present health evidence
to the public and patients. In this randomized controlled
trial, we have shown that the new format of the PLS im-
proves understanding of benefits and harms, is accessible
and usable, and is preferred by most participants across
several countries. Understanding not only about the effects
of the interventions but also about the quality of evidence
was greater when communicated in qualitative statements,
as well as in numbers and symbols. Contrary to concerns
about whether patients or the public would be able to un-
derstand such detailed information about effects of inter-
ventions, our findings support communication of those
elements. Indeed, our results showed that far fewer partic-
ipants who were provided with the narrative format
answered questions correctly about the benefits and harms,
the primary outcome of our study. We also found that re-
spondents found information about benefits and harms
more easily and thought the information was accessible
and usable with the new format. These findings and results
of previous research should encourage organizations
communicating evidence from synthesized research to pro-
vide detailed information about effects and quality ofNew format Current format Difference, % P-value
lowa 53% (31) 18% (17) 35 !0.001b
ng a cold
old
rtain?a
43% 2% 41 !0.001
as people
decrease
d?a
47% 40% 7 0.42
k (such as
ll catch a
64% 17% 47 !0.001
oses of
tarts, they
45% 19% 26 0.001
ing a cold
on), how
old last if
before the
65% 10% 55 !0.001
lts of a
No)
32% 45% 13 0.17
correct
ochrane
89% 67% 22 0.001
ding and understanding of benefits and harms and quality of evidence.
ce P ! 0.001.
Fig. 4. Assessment of usability and accessibility by new or current format.
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table [4e6,14,15].
This study, albeit relatively small, found no difference in
the effects of the new format across different languages,
across education levels or experience using the Internet. It
provides evidence that the new PLS format may be preferred
by a broad range of patients and the public, including people
in different countries and education levels. Results from this
trial also confirm our findings from our qualitative work
which found that participants liked summaries divided into
headings in a question and answer format and liked the flow
of information in our new format [6].
This study has several strengths including its random-
ized design and the careful developmental work that pre-
ceded this new format for PLS [4e6,14,15]. Conducting
the trial in several languages and settings is another
strength. However, our study has limitations. Of the 193
participants who initially agreed to participate in the study,
143 completed the study. However, we did not observe a
large difference in completion rates in the two arms of
the trial. We also did not engage respondents in real-lifedecisions. Instead, we chose a common topic, Vitamin C
for the common cold, to ensure that respondents could
relate to the health care information and we felt that many
people not only understood the topic but had likely thought
about the use of vitamin supplements to prevent and treat a
common cold in the past or were presently thinking about
it. Although we recruited participants from several coun-
tries, respondents came primarily from high-income and
middle-income countries, and it is unclear how the results
of this study apply to patients or the public from low-
income countries. Furthermore, recruitment through con-
sumer and personal networks at the various Cochrane
groups may have led to selection of people with a special
interest in health information. However, the participants
had a broad range of educational backgrounds and, given
their interest in health information, would indeed be repre-
sentative of those seeking such information.
It may also be argued that we gave an unfair advantage
to people who received the new format, as we asked respon-
dents the specific number of people who experienced an
outcome, and provided quantitative information in the
190 N. Santesso et al. / Journal of Clinical Epidemiology 68 (2015) 182e190new format but not in the current format. We use the same
argument put forth by Schwartz and Woloshin [5]. These
authors described that decisions following narrative provi-
sion of information are based on implicit assumptions about
the magnitude of the effect. Therefore, it is critical to eval-
uate if these assumptions are correct. In our study, in fact,
we found that respondents were incorrectly estimating the
size of the effect after reading the narrative summary in
the current format.
Despite our careful development work and improved pre-
sentation of the PLS, only up to 65% of participants answered
most comprehension questions correctly. It is unclear why this
occurred, and it indicates that morework should be conducted
to explore the best ways to communicate information, such as
whether to present absolute effects as natural frequencies or as
percentages [2,4]. We also presented quantitative information
with confidence intervals, and it is not clear whether the con-
fidence intervals were helpful or distracting. In addition, this
work is one of the first studies to explore the communication
of the effects of an intervention and the quality of the evi-
dence. In another study, we found that patients preferred
knowing about the underlying quality of evidence related to
intervention effects [7]. In our study, understanding was
improved with the new PLS, but fewer than 50% of the partic-
ipants answered the questions about quality of evidence
correctly. Certainly there is room for improvement and this
will be explored in a project by the GRADE working group
in which additional user testing and randomized controlled
trials about communication of evidence and recommenda-
tions from guidelines will be conducted with patients and
the public (www.decide-collaboration.eu).
In summary, we created a new format to translate syn-
thesized evidence from a Cochrane systematic review into
a PLS in multiple languages and found that the public
preferred this new format over the current format, found
the information more easily, and thought the information
was accessible and usable. These results could encourage
knowledge translation specialists, guideline developers, ed-
itors, and researchers from many organizations, such as
health technology assessment agencies, and the Cochrane
Collaboration to consider the use of this format to commu-
nicate results of systematic reviews to the public.Acknowledgments
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